Tenormin (atenolol) NDC 24979-245

NDC codes

FDA NDC Directory

Product NDC (as listed)24979-245Labeler and product segments. Claims need a package NDC.

Product NDC at billing width24979-0245Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
24979-245-07	24979024507	90 TABLET in 1 BOTTLE (24979-245-07)Marketed from Aug 1, 2024

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Tenormin
Generic name (nonproprietary): atenolol
Active ingredients: Atenolol — 50 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Upsher-Smith Laboratories, LLC
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication NDA 018240
Marketing start: Aug 1, 2024
Listing expires: Dec 31, 2027
Other FDA classes: Adrenergic beta-Antagonists (Mechanism)
Identifiers: Product ID 24979-245_c804fa73-5b5a-4e20-a1f5-6a13155df21fSPL ID c804fa73-5b5a-4e20-a1f5-6a13155df21fSPL set ID 6e850b1e-28a4-4ff8-8ed7-bb0b29faa28aRxCUI 150750, 152414, 197379, 197380, 197381, 201322UNII 50VV3VW0TIUPC 0324979246079, 0324979245072, 0324979244075
Pharmacologic class: beta-Adrenergic Blocker

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N424979024507 followed by a unit qualifier and the quantity

Package 24979-0245-07. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Sep 18, 2025.

Indications (excerpt from the label)

INDICATIONS AND USAGE Hypertension TENORMIN is indicated for the treatment of hypertension, to lower blood pressure. Lowering blood pressure lowers the risk of fatal and non-fatal cardiovascular events, primarily strokes and myocardial infarctions. These benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including atenolol. Control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. Many patients will require more than 1 drug to achieve blood pressure g…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under NDA 018240

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under NDA 018240
Product	Strength	Form · route	Labeler	Product NDC
Tenorminatenolol	Atenolol 25 mg/1	TabletOral	Upsher-Smith Laboratories, LLC	24979-244
Tenorminatenolol	Atenolol 100 mg/1	TabletOral	Upsher-Smith Laboratories, LLC	24979-246
Tenorminatenolol	Atenolol 50 mg/1	TabletOral	Almatica Pharma LLC	52427-430